SCHEMBL972121

SCHEMBL972121

Cc1ccc(F)[c]c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160251 0.79
SCHEMBL15063829 0.78
SCHEMBL6486806 0.76
SCHEMBL260518 0.74
SCHEMBL27496672 0.71 PTGS2 (0.41)
SCHEMBL29212774 0.70 TUBB1 (0.31)
SCHEMBL15063635 0.67 GABRA1 (0.31)
SCHEMBL8386937 0.67 LMNA (0.31)
SCHEMBL1068238 0.67 CA2 (0.37)
SCHEMBL596981 0.67 APOBEC3G (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115232175-B Fluorine-containing quasi-C2 symmetrical silicon bridged metallocene complex and application thereof 山东金诚石化集团有限公司 2024-06-14 CN claimed
CN-115368417-A Fluorine-containing C1 symmetric silicon bridged metallocene complex and application thereof 山东清河化工科技有限公司 2022-11-22 CN claimed
CN-115232175-A Fluorine-containing quasi-C2 symmetric silicon bridged metallocene complex and application thereof 山东清河化工科技有限公司 2022-10-25 CN claimed
CN-108026094-B Substituted 4-azaindoles and their use as modulators of the GLUN2B receptor 詹森药业有限公司 2021-02-09 CN claimed
EP-3319963-B1 SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-01-08 EP claimed
CN-106220572-B Pyridazine derivative compound, application, composition and kit and preparation method 因西必泰克新有限公司 2019-12-13 CN claimed
US-10377753-B2 Substituted 4-azaindoles and their use as GluN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2019-08-13 US claimed
EP-3243815-B1 PYRIDAZINE DERIVATIVES USEFUL IN THERAPY INHIBITAXIN LTD (GB) 2019-07-10 EP claimed
US-10016420-B2 Substituted pyridazines for the treatment of pain INHIBITAXIN LIMITED (GB) 2018-07-10 US claimed
EP-3319963-A1 SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2018-05-16 EP claimed
US-20050113423-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2005-05-26 US claimed
US-20050096376-A1 Substituted 3-pyrrolidine-indole derivatives GRUENENTHAL GMBH (DE) 2005-05-05 US claimed
JP-2005511694-A 2005-04-28 JP claimed
US-20050014815-A1 Substituted 2-pyrrolidine-2-yl-1H-indole compounds GRUENENTHAL GMBH (DE) 2005-01-20 US claimed
US-20040192916-A1 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives and related treatment methods GRUENENTHAL GMBH (DE) 2004-09-30 US claimed
WO-2004080972-A1 PIRAZOLE MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-09-23 WO claimed
EP-1451177-A1 SUBSTITUTED 2-PYRROLIDINE-2-YL-1H-INDOLE DERIVATIVES FOR THE TREATMENT OF MIGRAINE Grünenthal GmbH (DE) 2004-09-01 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003048156-A1 SUBSTITUTED 2-PYRROLIDINE-2-YL-1H-INDOLE DERIVATIVES FOR THE TREATMENT OF MIGRAINE Grünenthal GmbH (DE) 2003-06-12 WO claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed